38
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluating the possible genotoxicity of nanoaluminum incorporated in human vaccines and the potential protective role of nanocurcumin: an in vivo study

, , , , , & show all
Received 09 Apr 2024, Accepted 02 May 2024, Published online: 22 May 2024

References

  • Abbas OA, Ibrahim IG, Ismail AG. 2019. Therapeutic effects of nano-HAp in a rat model of AlCl3 induced neurotoxicity. IJPR. 18(3):1309.
  • Abouelkeir AR, Ghaleb SS, Shaker OG, Ibrahim HA, Alsaeed SA, Moawad AM, Elkady NK. 2023. Evaluation of the histopathological, immunohistochemical, and oxidative neurotoxic effects of nanoaluminum present in human vaccines in newborn albino rats. Eur. Chem. Bull. 12(1):3658–3681.
  • Abou-Zeid SM, Elkhadrawey BA, Anis A, AbuBakr HO, El-Bialy BE, Elsabbagh HS, El-Borai NB. 2021. Neuroprotective effect of sesamol against aluminum nanoparticle-induced toxicity in rats. Environ Sci Pollut Res Int. 28(38):53767–53780. doi: 10.1007/s11356-021-14587-x.
  • Alghriany AA, Omar HE, Mahmoud AM, Atia MM. 2022. Assessment of the toxicity of aluminum oxide and its nanoparticles in the bone marrow and liver of Male mice: ameliorative efficacy of curcumin nanoparticles. ACS Omega. 7(16):13841–13852. doi: 10.1021/acsomega.2c00195.
  • Bishop NJ, Morley R, Day JP, Lucas A. 1997. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med. 336(22):1557–1561. doi: 10.1056/NEJM199705293362203.
  • Danielsson R, Sandberg T, Eriksson H. 2018. Aluminum adjuvants–a nanomaterial used as adjuvants in human vaccines for decades. TOBIOTJ. 12(1):140–153. doi: 10.2174/1874070701812010140.
  • Dórea JG, Marques RC. 2010. Infants’ exposure to aluminum from vaccines and breast milk during the first 6 months. J Expo Sci Environ Epidemiol. 20(7):598–601. doi: 10.1038/jes.2009.64.
  • Eickhoff TC, Myers M. 2002. Workshop summary. Aluminum in vaccines. Vaccine. 20 Suppl 3:s 1–S4. doi: 10.1016/s0264-410x(02)00163-9.
  • Glenny AT, Pope CG, Waddington H, Wallace U. 1925. Immunological notes. VIII.-XVI. J Pathol. 28(3):463–482. doi: 10.1002/path.1700280308.
  • Gupta RK. 1998. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev. 32(3):155–172. doi: 10.1016/s0169-409x(98)00008-8.
  • HogenEsch H, O’Hagan DT, Fox CB. 2018. Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want. NPJ Vaccines. 3(1):51. doi: 10.1038/s41541-018-0089-x.
  • Jalili P, Huet S, Lanceleur R, Jarry G, Hegarat LL, Nesslany F, Hogeveen K, Fessard V. 2020. Genotoxicity of aluminum and aluminum oxide nanomaterials in rats following oral exposure. Nanomaterials. 10(2):305. doi: 10.3390/nano10020305.
  • Khadrawy YA, Hosny EN, Mohammed HS. 2021. Protective effect of nano curcumin against neurotoxicity induced by doxorubicin in rat’s brain. Neurotoxicology. 85:1–9. doi: 10.1016/j.neuro.2021.04.003.
  • Krausz AE, Adler BL, Cabral V, Navati M, Doerner J, Charafeddine RA, Chandra D, Liang H, Gunther L, Clendaniel A, et al. 2015. Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine. 11(1):195–206. doi: 10.1016/j.nano.2014.09.004.
  • Laera D, HogenEsch H, O’Hagan DT. 2023. Aluminum adjuvants—back to the future. Pharmaceutics. 15(7):1884. doi: 10.3390/pharmaceutics15071884.
  • Lindblad EB. 2004. Aluminum adjuvants—in retrospect and prospect. Vaccine. 22(27-28):3658–3668. doi: 10.1016/j.vaccine.2004.03.032.
  • Mrad I, Sakly M, Amara S. 2017. Aluminum oxide nanoparticles induced cognitive deficits and oxidative stress in frontal cortex and cerebellum of rat. Adv J Toxicol Curr Res. 1:007–014.
  • Ogolo NA, Onyekonwu MO. 2021. Effect of aluminum oxide nanoparticles on biotic factors of the environment Review. Arab J Chem Environ Res. 8:247–258.
  • Prabhakar PV, Reddy UA, Singh SP, Balasubramanyam A, Rahman MF, Indu Kumari S, Agawane SB, Murty US, Grover P, Mahboob M. 2012. Oxidative stress induced by aluminum oxide nanomaterials after acute oral treatment in Wistar rats. J Appl Toxicol. 32(6):436–445. doi: 10.1002/jat.1775.
  • Rajiv S, Jerobin J, Saranya V, Nainawat M, Sharma A, Makwana P, Gayathri C, Bharath L, Singh M, Kumar M, et al. 2016. Comparative cytotoxicity and genotoxicity of cobalt (II, III) oxide, iron (III) oxide, silicon dioxide, and aluminum oxide nanoparticles on human lymphocytes in vitro. Hum Exp Toxicol. 35(2):170–183. doi: 10.1177/0960327115579208.
  • Sarawi WS, Alhusaini AM, Fadda LM, Alomar HA, Albaker AB, AljrboaAS, Alotaibi AM, Hasan IH, Mahmoud AM. 2021. Curcumin and nanocurcumin mitigate copper neurotoxicity by modulating oxidative stress, inflammation, and akt/gsk-3β signaling. Molecules. 26(18):5591. doi: 10.3390/molecules26185591.
  • Seneff S, Davidson RM, Liu J. 2012. Empirical data confirm autism symptoms related to aluminum and acetaminophen exposure. Entropy. 14(11):2227–2253. doi: 10.3390/e14112227.
  • Shaw CA, Li Y, Tomljenovic L. 2013. Administration of aluminum to neonatal mice in vaccine-relevant amounts is associated with adverse long-term neurological outcomes. J Inorg Biochem. 128:237–244. doi: 10.1016/j.jinorgbio.2013.07.022.
  • Shirodkar S, Hutchinson RL, Perry DL, White JL, Hem SL. 1990. Aluminum compounds are used as adjuvants in vaccines. Pharm Res. 7(12):1282–1288. doi: 10.1023/a:1015994006859.
  • Tomljenovic L, Shaw CA. 2011. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem. 105(11):1489–1499. doi: 10.1016/j.jinorgbio.2011.08.008.
  • Tomljenovic L. 2011. Aluminum and Alzheimer’s disease: after a century of controversy, is there a plausible link? J Alzheimers Dis. 23(4):567–598. doi: 10.3233/JAD-2010-101494.
  • Wang M, Chen JT, Ruan DY, Xu YZ. 2002. The influence of developmental period of aluminum exposure on synaptic plasticity in the adult rat dentate gyrus in vivo. Neuroscience. 113(2):411–419. doi: 10.1016/s0306-4522(02)00193-8.
  • Yousef MI, Al-Hamadani M, Kamel M. 2019. Reproductive toxicity of aluminum oxide nanoparticles and zinc oxide nanoparticles in male rats. Nano Particle. 1(1):3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.